BetterLife Pharma Stock Forecast, Price & News

-0.01 (-1.49 %)
(As of 04/15/2021 12:00 AM ET)
Today's Range
Now: $0.66
50-Day Range
MA: $1.03
52-Week Range
Now: $0.66
Volume24,489 shs
Average Volume85,848 shs
Market Capitalization$11.37 million
P/E RatioN/A
Dividend YieldN/A
BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of psychedelic products for the treatment of mental disorders in Canada, the United States, Australia, and European Union. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections, such as coronavirus disease and human papillomavirus, and/or to directly inhibit tumours to treat various types of cancer. BetterLife Pharma Inc. has a research agreement with the University of California San Diego for preclinical behavioral pharmacology studies of TD-0148A, a lysergic acid diethylamide derivative solution. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was founded in 2002 and is headquartered in Vancouver, Canada.
BetterLife Pharma logo

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Phone(604) 805-7783
Year FoundedN/A



Sales & Book Value

Annual SalesN/A
Book Value$0.12 per share


Net Income$-14,780,000.00


Market Cap$11.37 million
Next Earnings Date6/7/2021 (Estimated)
OptionableNot Optionable


See More Headlines


Overall MarketRank

0.00 out of 5 stars

Medical Sector

1984th out of 2,021 stocks

Pharmaceutical Preparations Industry

767th out of 772 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
-0.01 (-1.49 %)
(As of 04/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BETRF News and Ratings via Email

Sign-up to receive the latest news and ratings for BETRF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

BetterLife Pharma (OTCMKTS:BETRF) Frequently Asked Questions

What stocks does MarketBeat like better than BetterLife Pharma?

Wall Street analysts have given BetterLife Pharma a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but BetterLife Pharma wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting BetterLife Pharma?

BetterLife Pharma saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 15,500 shares, an increase of 3,000.0% from the March 15th total of 500 shares. Based on an average daily volume of 70,000 shares, the days-to-cover ratio is currently 0.2 days.
View BetterLife Pharma's Short Interest

When is BetterLife Pharma's next earnings date?

BetterLife Pharma is scheduled to release its next quarterly earnings announcement on Monday, June 7th 2021.
View our earnings forecast for BetterLife Pharma

Who are BetterLife Pharma's key executives?

BetterLife Pharma's management team includes the following people:
  • Dr. Ahmad Doroudian, Founder, CEO & Director (Age 61, Pay $133.33k)
  • Ms. Moira Ong C.A., CPA, CA, CFA, Chief Financial Officer (Age 46, Pay $120k)
  • Mr. Patrick Kroupa, Chief Psychedelics Officer
  • Mr. Justin Kirkland, Chief Psychedelics Scientist

Who are some of BetterLife Pharma's key competitors?

What is BetterLife Pharma's stock symbol?

BetterLife Pharma trades on the OTCMKTS under the ticker symbol "BETRF."

How do I buy shares of BetterLife Pharma?

Shares of BETRF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BetterLife Pharma's stock price today?

One share of BETRF stock can currently be purchased for approximately $0.66.

How much money does BetterLife Pharma make?

BetterLife Pharma has a market capitalization of $11.37 million.

How many employees does BetterLife Pharma have?

BetterLife Pharma employs 7 workers across the globe.

What is BetterLife Pharma's official website?

The official website for BetterLife Pharma is www.abetterlifepharma.com.

Where are BetterLife Pharma's headquarters?

BetterLife Pharma is headquartered at 1275 WEST 6TH AVENUE, VANCOUVER A1, V6H 1A6.

How can I contact BetterLife Pharma?

BetterLife Pharma's mailing address is 1275 WEST 6TH AVENUE, VANCOUVER A1, V6H 1A6. The company can be reached via phone at (604) 805-7783 or via email at [email protected]

This page was last updated on 4/16/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.